Investment Trusts

Target Healthcare REIT plc

THRL:LSE

Target Healthcare REIT plc

  • Price (GBX)105.00
  • Today's Change-1.40 / -1.32%
  • Shares traded860.06k
  • 1 Year change18.24%
  • Beta0.6868
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceTarget Healthcare REIT plc (Ordinary Share)+27.99%
NAVTarget Healthcare REIT plc (Ordinary Share)+9.73%
Morningstar's BenchmarkFTSE EPRA Nareit UK TR GBP--

Key statistics

On Friday, Target Healthcare REIT plc (THRL:LSE) closed at 105.00, -2.97% below its 52-week high of 108.21, set on Feb 04, 2026.
52-week range
Today
81.50Mar 06 2025108.21Feb 04 2026
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding620.24m
Market cap659.93m GBP
Total assets989.24m GBP
Total expense ratio--
High106.40
Low105.00
Previous close106.40
Average volume1.31m
YTD Change+7.58%
Beta0.6868
Diluted NAV (est)124.61
Diluted NAV (last pub)124.00
Premium/Discount-15.74%
Net Gearing+24.59%
Annual div (ADY)5.96 GBX
Annual div yield (ADY)5.60%
Div ex-dateNov 13 2025
Div pay-dateNov 28 2025
Next div ex-dateFeb 12 2026
Next div pay-dateFeb 27 2026
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.